| Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic … A Chanan-Khan, P Cramer, F Demirkan, G Fraser, RS Silva, S Grosicki, ... The Lancet Oncology 17 (2), 200-211, 2016 | 505 | 2016 |
| Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic … A Chanan-Khan, A (Chanan-Khan, 3 ] Cramer, P (Cramer, Paula)[ 2, ... LANCET ONCOLOGY 17 (2), 200-211, 2016 | 505 | 2016 |
| The effects of blood group types on the risk of COVID-19 infection and its clinical outcome H Göker, EA Karakulak, H Demiroğlu, ÇMA Ceylan, Y Büyükaşik, ... Turkish journal of medical sciences 50 (4), 679-683, 2020 | 219 | 2020 |
| Cytokines in Behçet's disease. N Sayinalp, OI Ozcebe, O Ozdemir, IC Haznedaroğlu, S Dündar, S Kirazli The Journal of rheumatology 23 (2), 321-322, 1996 | 204 | 1996 |
| Perianal infections in patients with leukemia: importance of the course of neutrophil count Y Büyükaşık, OI Özcebe, N Sayınalp, IC Haznedaroğlu, ÖÖ Altundağ, ... Diseases of the colon & rectum 41, 81-85, 1998 | 85 | 1998 |
| Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis A Gurgey, IC Haznedaroglu, T Egesel, Y Buyukasık, OI Ozcebe, ... American journal of hematology 67 (2), 107-111, 2001 | 66 | 2001 |
| Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease Y Buyukasik, S Karakus, H Goker, IC Haznedaroglu, D Ozatli, N Sayinalp, ... Blood coagulation & fibrinolysis 13 (4), 349-353, 2002 | 65 | 2002 |
| Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. Y Beyazit, S Aksu, IC Haznedaroglu, M Kekilli, M Misirlioglu, S Tuncer, ... Journal of the National Medical Association 99 (1), 57, 2007 | 64 | 2007 |
| Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma A Karataş, AÇ İnkaya, H Demiroğlu, S Aksu, T Haziyev, OE Çınar, A Alp, ... Transfusion and Apheresis Science 59 (5), 102871, 2020 | 59 | 2020 |
| Copper deficiency with increased hematogones mimicking refractory anemia with excess blasts E Koca, Y Buyukasik, D Cetiner, R Yilmaz, N Sayinalp, U Yasavul, A Uner Leukemia research 32 (3), 495-499, 2008 | 53 | 2008 |
| Thromboprophylaxis in hip fracture surgery: a pilot study comparing danaparoid, enoxaparin and dalteparin M Mukherjee, F DeLorenzo, Z Kadziola, A Rutlin, N Ranlall, K Sembhi, ... Pathophysiology of Haemostasis and Thrombosis 29 (6), 310-317, 1999 | 52 | 1999 |
| Effects of interferon-α2a treatment on serum levels of tumor necrosis factor-α, tumor necrosis factor-α2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in … A Kosar, S Haznedaroglu, Y Karaaslan, Y Büyükasik, IC Haznedaroglu, ... Rheumatology international 19, 11-14, 1999 | 51 | 1999 |
| Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML S Aksu, Y Beyazit, IC Haznedaroglu, H Canpinar, M Kekilli, A Uner, ... Leukemia & lymphoma 47 (5), 891-896, 2006 | 49 | 2006 |
| EUTOS CML prognostic scoring system predicts ELN-based ‘event-free survival’better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate B Uz, Y Buyukasik, H Atay, E Kelkitli, M Turgut, O Bektas, E Eliacik, A Isik, ... Hematology 18 (5), 247-252, 2013 | 48 | 2013 |
| Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis OE Çınar, B Sayınalp, EA Karakulak, AA Karataş, M Velet, AÇ İnkaya, ... Transfusion and Apheresis Science 59 (5), 102821, 2020 | 46 | 2020 |
| Neutropenic enterocolitis in adult leukemias. Y Büyükaşik, OI Ozcebe, IC Haznedaroğlu, N Sayinalp, AR Soylu, ... International journal of hematology 66 (1), 47-55, 1997 | 45 | 1997 |
| Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity M Gürsoy, IC Haznedaroğlu, I Çelik, N Sayinalp, OI Özcebe, SV Dündar, ... Annals of Pharmacotherapy 30 (7-8), 762-765, 1996 | 44 | 1996 |
| Evaluation of the haemostatic system during ketoacidotic deterioration of diabetes mellitus NŞ Ileri, Y Büyükaşık, S Karaahmetoglu, D Özatlı, N Sayınalp, Oİ Özcebe, ... Pathophysiology of Haemostasis and Thrombosis 29 (6), 318-325, 1999 | 43 | 1999 |
| Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia İC Haznedaroğlu, İ Ertenli, Oİ Özcebe, S Kiraz, O Özdemir, NM Sayinalp, ... Acta haematologica 95 (2), 107-111, 1996 | 43 | 1996 |
| Acute in vitro effects of ABS (Ankaferd Hemostat) on the lymphoid neoplastic cells (B-CLL and RAJI tumor cell lines) I Akalin, F Okur, İ HAZNEDAROĞLU, N SAYINALP, S Aksu, ... Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi 24 (4), 2014 | 35* | 2014 |
